What is the global metastatic melanoma cancer diagnostics market size in 2026?

The global metastatic melanoma cancer diagnostics market size is estimated at US$ 3.6 billion in 2026, and it is projected to reach about US$ 6.1 billion by 2033, reflecting a CAGR of approximately 7.8% during 2026–2033.

What is a key demand driver for metastatic melanoma cancer diagnostics?

A key demand driver is the rising incidence and prevalence of advanced melanoma, combined with the need for precise staging and monitoring as patients receive immunotherapies and targeted therapies, which increases utilization of biopsy, imaging, and molecular & biomarker tests.

Which region currently leads the metastatic melanoma cancer diagnostics market?

North America currently leads the metastatic melanoma cancer diagnostics market, supported by high melanoma incidence, well‑developed oncology networks, broad access to advanced imaging and molecular diagnostics, and strong innovation and reimbursement ecosystems in the United States and Canada.

What is a major opportunity area in this market?

A major opportunity lies in the expansion of liquid biopsy and AI-enabled diagnostic software, which can provide minimally invasive, real-time monitoring of tumor burden and treatment response, enhancing precision oncology and supporting value-based care models in metastatic melanoma.

Who are some of the key players in the metastatic melanoma cancer diagnostics market?

Key players include Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, QIAGEN N.V., Illumina, Inc., NeoGenomics Laboratories, Myriad Genetics, Castle Biosciences, Inc., DermTech, Inc., Quest Diagnostics Incorporated, Foundation Medicine, Inc., as well as Siemens Healthineers.

Table of Content - Metastatic Melanoma Cancer Diagnostics Market Size, Share, and Growth Forecast 2026

Executive Summary
1. Global Metastatic Melanoma Cancer Diagnostics Market Snapshot 2026 and 2033
2. Market Opportunity Assessment, 2026-2033, US$ Bn
3. Key Market Trends
4. Industry Developments and Key Market Events
5. Demand Side and Supply Side Analysis
6. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definitions
2. Market Dynamics
  1. Driver
  2. Restraint
  3. Opportunities
  4. Trends
3. Macro-Economic Factors
  1. Global GDP Outlook
  2. Global Healthcare Expenditure
4. Forecast Factors – Relevance and Impact
5. COVID-19 Impact Assessment
Value Added Insights
1. Value Chain analysis
2. Key Market Players
3. Test Adoption Analysis
4. Key Promotional Strategies by key players
5. PESTLE Analysis
6. Porter's Five Forces Analysis
7. Regulatory and Technology Landscape
Global Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Global Metastatic Melanoma Cancer Diagnostics Market Outlook: Diagnostic Type
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Diagnostic Type, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
    1. Biopsy Tests
    2. Imaging Tests
    3. Molecular & Biomarker Tests
  4. Market Attractiveness Analysis: Diagnostic Type
3. Global Metastatic Melanoma Cancer Diagnostics Market Outlook: Product Type
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Product Type, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
    1. Instruments & Devices
    2. Reagents & Test Kits
    3. Diagnostic Software
  4. Market Attractiveness Analysis: Product Type
4. Global Metastatic Melanoma Cancer Diagnostics Market Outlook: End User
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by End User, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by End User, 2026-2033
    1. Hospitals & Clinics
    2. Diagnostic Laboratories
    3. Oncology & Cancer Centers
    4. Research Institutes
  4. Market Attractiveness Analysis: End User
Global Metastatic Melanoma Cancer Diagnostics Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia & Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. U.S.
  2. Canada
3. North America Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
  1. Biopsy Tests
  2. Imaging Tests
  3. Molecular & Biomarker Tests
4. North America Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
  1. Instruments & Devices
  2. Reagents & Test Kits
  3. Diagnostic Software
5. North America Market Size (US$ Bn) Forecast, by End User, 2026-2033
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Oncology & Cancer Centers
  4. Research Institutes
Europe Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. Germany
  2. Italy
  3. France
  4. U.K.
  5. Spain
  6. Russia
  7. Rest of Europe
3. Europe Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
  1. Biopsy Tests
  2. Imaging Tests
  3. Molecular & Biomarker Tests
4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
  1. Instruments & Devices
  2. Reagents & Test Kits
  3. Diagnostic Software
5. Europe Market Size (US$ Bn) Forecast, by End User, 2026-2033
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Oncology & Cancer Centers
  4. Research Institutes
East Asia Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. China
  2. Japan
  3. South Korea
3. East Asia Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
  1. Biopsy Tests
  2. Imaging Tests
  3. Molecular & Biomarker Tests
4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
  1. Instruments & Devices
  2. Reagents & Test Kits
  3. Diagnostic Software
5. East Asia Market Size (US$ Bn) Forecast, by End User, 2026-2033
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Oncology & Cancer Centers
  4. Research Institutes
South Asia & Oceania Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of SAO
3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
  1. Biopsy Tests
  2. Imaging Tests
  3. Molecular & Biomarker Tests
4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
  1. Instruments & Devices
  2. Reagents & Test Kits
  3. Diagnostic Software
5. South Asia & Oceania Market Size (US$ Bn) Forecast, by End User, 2026-2033
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Oncology & Cancer Centers
  4. Research Institutes
Latin America Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. Brazil
  2. Mexico
  3. Rest of LATAM
3. Latin America Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
  1. Biopsy Tests
  2. Imaging Tests
  3. Molecular & Biomarker Tests
4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
  1. Instruments & Devices
  2. Reagents & Test Kits
  3. Diagnostic Software
5. Latin America Market Size (US$ Bn) Forecast, by End User, 2026-2033
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Oncology & Cancer Centers
  4. Research Institutes
Middle East & Africa Metastatic Melanoma Cancer Diagnostics Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
1. Key Highlights
2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. GCC Countries
  2. South Africa
  3. Northern Africa
  4. Rest of MEA
3. Middle East & Africa Market Size (US$ Bn) Forecast, by Diagnostic Type, 2026-2033
  1. Biopsy Tests
  2. Imaging Tests
  3. Molecular & Biomarker Tests
4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
  1. Instruments & Devices
  2. Reagents & Test Kits
  3. Diagnostic Software
5. Middle East & Africa Market Size (US$ Bn) Forecast, by End User, 2026-2033
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Oncology & Cancer Centers
  4. Research Institutes
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping
  2. Competition Dashboard
3. Company Profiles
  1. Roche Diagnostics
    1. Company Overview
    2. Product Portfolio/Offerings
    3. Key Financials
    4. SWOT Analysis
    5. Company Strategy and Key Developments
  2. Thermo Fisher Scientific
  3. Abbott Laboratories
  4. Agilent Technologies
  5. QIAGEN N.V.
  6. Illumina, Inc.
  7. NeoGenomics Laboratories
  8. Myriad Genetics
  9. Castle Biosciences, Inc.
  10. DermTech, Inc.
  11. Quest Diagnostics Incorporated
  12. Foundation Medicine, Inc.
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Metastatic Melanoma Cancer Diagnostics Market Size, Share, and Growth Forecast 2026 – 2033

Quick Links

Our Partners

Secure Payments Through